APO Research
Talk to an analyst

APO RESEARCH · REPORT

Polymyxin B Sulfate API

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Polymyxin B Sulfate API Market Outlook and Growth Opportunities 2026

23 December 2025197 pages

Choose your research edition.

Industry ResearchPolymyxin B Sulfate API Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Polymyxin B Sulfate API Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Polymyxin B Sulfate API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Polymyxin B Sulfate API Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Polymyxin B Sulfate API Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Polymyxin B Sulfate API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Polymyxin B Sulfate API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Polymyxin B Sulfate API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Polymyxin B Sulfate API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Polymyxin B Sulfate API market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Polymyxin B Sulfate API market include Yancheng Youhua Pharmaceutical And Chemical Technology, Shandong Luxi Pharmaceutical, Jiangxi Nuclear Industry Reyphon Bio-Chemical, North China Pharmaceutical Huasheng, Hangzhou Zhongmei Huadong Pharmaceutical, Ganzhou Ruizhi Pharmaceutical, Xellia Pharmaceuticals Aps, Rochem International and Medisca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Polymyxin B Sulfate API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Polymyxin B Sulfate API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Polymyxin B Sulfate API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Polymyxin B Sulfate API market size, projected growth trends, production technologies, key applications, and end-use industries.

Polymyxin B Sulfate API Segment by Company

Yancheng Youhua Pharmaceutical And Chemical Technology

Shandong Luxi Pharmaceutical

Jiangxi Nuclear Industry Reyphon Bio-Chemical

North China Pharmaceutical Huasheng

Hangzhou Zhongmei Huadong Pharmaceutical

Ganzhou Ruizhi Pharmaceutical

Xellia Pharmaceuticals Aps

Rochem International

Medisca

LGM Pharma

ChemWerth

Biotika As

Alp Pharm

Polymyxin B Sulfate API Segment by Type

Purity ≥99%

95%≤purity≤99%

Polymyxin B Sulfate API Segment by Application

Injection

Others

Polymyxin B Sulfate API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Polymyxin B Sulfate API status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Polymyxin B Sulfate API market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Polymyxin B Sulfate API significant trends, drivers, influence factors in global and regions.

6. To analyze Polymyxin B Sulfate API competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polymyxin B Sulfate API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Polymyxin B Sulfate API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polymyxin B Sulfate API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Polymyxin B Sulfate API market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Polymyxin B Sulfate API industry.

Chapter 3: Detailed analysis of Polymyxin B Sulfate API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Polymyxin B Sulfate API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Polymyxin B Sulfate API in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Polymyxin B Sulfate API Industry Trends Table 2. Polymyxin B Sulfate API Industry Drivers Table 3. Polymyxin B Sulfate API Industry Opportunities and Challenges Table 4. Polymyxin B Sulfate API Industry Restraints Table 5. Global Polymyxin B Sulfate API Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Polymyxin B Sulfate API Revenue Share by Company (2021-2026) Table 7. Global Polymyxin B Sulfate API Sales Volume by Company (t) & (2021-2026) Table 8. Global Polymyxin B Sulfate API Sales Volume Share by Company (2021-2026) Table 9. Global Polymyxin B Sulfate API Average Price (USD/kg) of Company (2021-2026) Table 10. Global Polymyxin B Sulfate API Company Ranking, (2024-2026) & (USD Million) Table 11. Global Polymyxin B Sulfate API Key Company Manufacturing Base & Headquarters Table 12. Global Polymyxin B Sulfate API Company, Product Type & Application Table 13. Global Polymyxin B Sulfate API Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Polymyxin B Sulfate API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Purity ≥99% Table 18. Significant Companies of 95%≤purity≤99% Table 19. Global Polymyxin B Sulfate API Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 20. Global Polymyxin B Sulfate API Sales Volume by Type (2021-2026) & (t) Table 21. Global Polymyxin B Sulfate API Sales Volume by Type (2027-2032) & (t) Table 22. Global Polymyxin B Sulfate API Sales Volume Share by Type (2021-2026) Table 23. Global Polymyxin B Sulfate API Sales Volume Share by Type (2027-2032) Table 24. Global Polymyxin B Sulfate API Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Polymyxin B Sulfate API Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Polymyxin B Sulfate API Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Polymyxin B Sulfate API Sales Value Share by Type (2021-2026) Table 28. Global Polymyxin B Sulfate API Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Injection Table 30. Significant Companies of Others Table 31. Global Polymyxin B Sulfate API Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 32. Global Polymyxin B Sulfate API Sales Volume by Application (2021-2026) & (t) Table 33. Global Polymyxin B Sulfate API Sales Volume by Application (2027-2032) & (t) Table 34. Global Polymyxin B Sulfate API Sales Volume Share by Application (2021-2026) Table 35. Global Polymyxin B Sulfate API Sales Volume Share by Application (2027-2032) Table 36. Global Polymyxin B Sulfate API Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Polymyxin B Sulfate API Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Polymyxin B Sulfate API Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Polymyxin B Sulfate API Sales Value Share by Application (2021-2026) Table 40. Global Polymyxin B Sulfate API Sales Value Share by Application (2027-2032) Table 41. Global Polymyxin B Sulfate API Sales by Region: 2021 VS 2025 VS 2032 (t) Table 42. Global Polymyxin B Sulfate API Sales by Region (2021-2026) & (t) Table 43. Global Polymyxin B Sulfate API Sales Market Share by Region (2021-2026) Table 44. Global Polymyxin B Sulfate API Sales by Region (2027-2032) & (t) Table 45. Global Polymyxin B Sulfate API Sales Market Share by Region (2027-2032) Table 46. Global Polymyxin B Sulfate API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Polymyxin B Sulfate API Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Polymyxin B Sulfate API Sales Value Share by Region (2021-2026) Table 49. Global Polymyxin B Sulfate API Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Polymyxin B Sulfate API Sales Value Share by Region (2027-2032) Table 51. Global Polymyxin B Sulfate API Market Average Price (USD/kg) by Region (2021-2026) Table 52. Global Polymyxin B Sulfate API Market Average Price (USD/kg) by Region (2027-2032) Table 53. Global Polymyxin B Sulfate API Sales by Country: 2021 VS 2025 VS 2032 (t) Table 54. Global Polymyxin B Sulfate API Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Polymyxin B Sulfate API Sales by Country (2021-2026) & (t) Table 56. Global Polymyxin B Sulfate API Sales Market Share by Country (2021-2026) Table 57. Global Polymyxin B Sulfate API Sales by Country (2027-2032) & (t) Table 58. Global Polymyxin B Sulfate API Sales Market Share by Country (2027-2032) Table 59. Global Polymyxin B Sulfate API Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Polymyxin B Sulfate API Sales Value Market Share by Country (2021-2026) Table 61. Global Polymyxin B Sulfate API Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Polymyxin B Sulfate API Sales Value Market Share by Country (2027-2032) Table 63. Yancheng Youhua Pharmaceutical And Chemical Technology Company Information Table 64. Yancheng Youhua Pharmaceutical And Chemical Technology Business Overview Table 65. Yancheng Youhua Pharmaceutical And Chemical Technology Polymyxin B Sulfate API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 66. Yancheng Youhua Pharmaceutical And Chemical Technology Polymyxin B Sulfate API Product Portfolio Table 67. Yancheng Youhua Pharmaceutical And Chemical Technology Recent Development Table 68. Shandong Luxi Pharmaceutical Company Information Table 69. Shandong Luxi Pharmaceutical Business Overview Table 70. Shandong Luxi Pharmaceutical Polymyxin B Sulfate API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 71. Shandong Luxi Pharmaceutical Polymyxin B Sulfate API Product Portfolio Table 72. Shandong Luxi Pharmaceutical Recent Development Table 73. Jiangxi Nuclear Industry Reyphon Bio-Chemical Company Information Table 74. Jiangxi Nuclear Industry Reyphon Bio-Chemical Business Overview Table 75. Jiangxi Nuclear Industry Reyphon Bio-Chemical Polymyxin B Sulfate API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 76. Jiangxi Nuclear Industry Reyphon Bio-Chemical Polymyxin B Sulfate API Product Portfolio Table 77. Jiangxi Nuclear Industry Reyphon Bio-Chemical Recent Development Table 78. North China Pharmaceutical Huasheng Company Information Table 79. North China Pharmaceutical Huasheng Business Overview Table 80. North China Pharmaceutical Huasheng Polymyxin B Sulfate API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 81. North China Pharmaceutical Huasheng Polymyxin B Sulfate API Product Portfolio Table 82. North China Pharmaceutical Huasheng Recent Development Table 83. Hangzhou Zhongmei Huadong Pharmaceutical Company Information Table 84. Hangzhou Zhongmei Huadong Pharmaceutical Business Overview Table 85. Hangzhou Zhongmei Huadong Pharmaceutical Polymyxin B Sulfate API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 86. Hangzhou Zhongmei Huadong Pharmaceutical Polymyxin B Sulfate API Product Portfolio Table 87. Hangzhou Zhongmei Huadong Pharmaceutical Recent Development Table 88. Ganzhou Ruizhi Pharmaceutical Company Information Table 89. Ganzhou Ruizhi Pharmaceutical Business Overview Table 90. Ganzhou Ruizhi Pharmaceutical Polymyxin B Sulfate API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 91. Ganzhou Ruizhi Pharmaceutical Polymyxin B Sulfate API Product Portfolio Table 92. Ganzhou Ruizhi Pharmaceutical Recent Development Table 93. Xellia Pharmaceuticals Aps Company Information Table 94. Xellia Pharmaceuticals Aps Business Overview Table 95. Xellia Pharmaceuticals Aps Polymyxin B Sulfate API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 96. Xellia Pharmaceuticals Aps Polymyxin B Sulfate API Product Portfolio Table 97. Xellia Pharmaceuticals Aps Recent Development Table 98. Rochem International Company Information Table 99. Rochem International Business Overview Table 100. Rochem International Polymyxin B Sulfate API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 101. Rochem International Polymyxin B Sulfate API Product Portfolio Table 102. Rochem International Recent Development Table 103. Medisca Company Information Table 104. Medisca Business Overview Table 105. Medisca Polymyxin B Sulfate API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 106. Medisca Polymyxin B Sulfate API Product Portfolio Table 107. Medisca Recent Development Table 108. LGM Pharma Company Information Table 109. LGM Pharma Business Overview Table 110. LGM Pharma Polymyxin B Sulfate API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 111. LGM Pharma Polymyxin B Sulfate API Product Portfolio Table 112. LGM Pharma Recent Development Table 113. ChemWerth Company Information Table 114. ChemWerth Business Overview Table 115. ChemWerth Polymyxin B Sulfate API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 116. ChemWerth Polymyxin B Sulfate API Product Portfolio Table 117. ChemWerth Recent Development Table 118. Biotika As Company Information Table 119. Biotika As Business Overview Table 120. Biotika As Polymyxin B Sulfate API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 121. Biotika As Polymyxin B Sulfate API Product Portfolio Table 122. Biotika As Recent Development Table 123. Alp Pharm Company Information Table 124. Alp Pharm Business Overview Table 125. Alp Pharm Polymyxin B Sulfate API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 126. Alp Pharm Polymyxin B Sulfate API Product Portfolio Table 127. Alp Pharm Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Polymyxin B Sulfate API Distributors List Table 131. Polymyxin B Sulfate API Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Polymyxin B Sulfate API Product Image Figure 2. Global Polymyxin B Sulfate API Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Polymyxin B Sulfate API Sales Value (2021-2032) & (US$ Million) Figure 4. Global Polymyxin B Sulfate API Sales (2021-2032) & (t) Figure 5. Global Polymyxin B Sulfate API Sales Average Price (USD/kg) & (2021-2032) Figure 6. Global Polymyxin B Sulfate API Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity ≥99% Image Figure 10. 95%≤purity≤99% Image Figure 11. Global Polymyxin B Sulfate API Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 12. Global Polymyxin B Sulfate API Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Polymyxin B Sulfate API Sales Volume Share by Type (2021-2032) Figure 14. Global Polymyxin B Sulfate API Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Polymyxin B Sulfate API Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Polymyxin B Sulfate API Sales Value Share by Type (2021-2032) Figure 17. Injection Image Figure 18. Others Image Figure 19. Global Polymyxin B Sulfate API Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 20. Global Polymyxin B Sulfate API Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Polymyxin B Sulfate API Sales Volume Share by Application (2021-2032) Figure 22. Global Polymyxin B Sulfate API Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Polymyxin B Sulfate API Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Polymyxin B Sulfate API Sales Value Share by Application (2021-2032) Figure 25. Global Polymyxin B Sulfate API Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 26. Global Polymyxin B Sulfate API Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Polymyxin B Sulfate API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Polymyxin B Sulfate API Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Polymyxin B Sulfate API Sales Value (2021-2032) & (US$ Million) Figure 30. North America Polymyxin B Sulfate API Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Polymyxin B Sulfate API Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Polymyxin B Sulfate API Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Polymyxin B Sulfate API Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Polymyxin B Sulfate API Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Polymyxin B Sulfate API Sales Value (2021-2032) & (US$ Million) Figure 36. South America Polymyxin B Sulfate API Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Polymyxin B Sulfate API Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Polymyxin B Sulfate API Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Polymyxin B Sulfate API Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Polymyxin B Sulfate API Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≥99%
  • 95%≤purity≤99%
Applications
  • Injection
  • Others
Companies covered
  • Yancheng Youhua Pharmaceutical And Chemical Technology
  • Shandong Luxi Pharmaceutical
  • Jiangxi Nuclear Industry Reyphon Bio-Chemical
  • North China Pharmaceutical Huasheng
  • Hangzhou Zhongmei Huadong Pharmaceutical
  • Ganzhou Ruizhi Pharmaceutical
  • Xellia Pharmaceuticals Aps
  • Rochem International
  • Medisca
  • LGM Pharma
  • ChemWerth
  • Biotika As
  • Alp Pharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Polymyxin B Sulfate API Sales Value (2021-2032)
  4. 1.2.2 Global Polymyxin B Sulfate API Sales Volume (2021-2032)
  5. 1.2.3 Global Polymyxin B Sulfate API Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Polymyxin B Sulfate API Market Dynamics
  1. 2.1 Polymyxin B Sulfate API Industry Trends
  2. 2.2 Polymyxin B Sulfate API Industry Drivers
  3. 2.3 Polymyxin B Sulfate API Industry Opportunities and Challenges
  4. 2.4 Polymyxin B Sulfate API Industry Restraints
3 Polymyxin B Sulfate API Market by Company
  1. 3.1 Global Polymyxin B Sulfate API Company Revenue Ranking in 2025
  2. 3.2 Global Polymyxin B Sulfate API Revenue by Company (2021-2026)
  3. 3.3 Global Polymyxin B Sulfate API Sales Volume by Company (2021-2026)
  4. 3.4 Global Polymyxin B Sulfate API Average Price by Company (2021-2026)
  5. 3.5 Global Polymyxin B Sulfate API Company Ranking (2024-2026)
  6. 3.6 Global Polymyxin B Sulfate API Company Manufacturing Base and Headquarters
  7. 3.7 Global Polymyxin B Sulfate API Company Product Type and Application
  8. 3.8 Global Polymyxin B Sulfate API Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Polymyxin B Sulfate API Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Polymyxin B Sulfate API Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Polymyxin B Sulfate API Market by Type
  1. 4.1 Polymyxin B Sulfate API Type Introduction
  2. 4.1.1 Purity ≥99%
  3. 4.1.2 95%≤purity≤99%
  4. 4.2 Global Polymyxin B Sulfate API Sales Volume by Type
  5. 4.2.1 Global Polymyxin B Sulfate API Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Polymyxin B Sulfate API Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Polymyxin B Sulfate API Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Polymyxin B Sulfate API Sales Value by Type
  9. 4.3.1 Global Polymyxin B Sulfate API Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Polymyxin B Sulfate API Sales Value by Type (2021-2032)
  11. 4.3.3 Global Polymyxin B Sulfate API Sales Value Share by Type (2021-2032)
5 Polymyxin B Sulfate API Market by Application
  1. 5.1 Polymyxin B Sulfate API Application Introduction
  2. 5.1.1 Injection
  3. 5.1.2 Others
  4. 5.2 Global Polymyxin B Sulfate API Sales Volume by Application
  5. 5.2.1 Global Polymyxin B Sulfate API Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Polymyxin B Sulfate API Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Polymyxin B Sulfate API Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Polymyxin B Sulfate API Sales Value by Application
  9. 5.3.1 Global Polymyxin B Sulfate API Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Polymyxin B Sulfate API Sales Value by Application (2021-2032)
  11. 5.3.3 Global Polymyxin B Sulfate API Sales Value Share by Application (2021-2032)
6 Polymyxin B Sulfate API Regional Sales and Value Analysis
  1. 6.1 Global Polymyxin B Sulfate API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Polymyxin B Sulfate API Sales by Region (2021-2032)
  3. 6.2.1 Global Polymyxin B Sulfate API Sales by Region: 2021-2026
  4. 6.2.2 Global Polymyxin B Sulfate API Sales by Region (2027-2032)
  5. 6.3 Global Polymyxin B Sulfate API Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Polymyxin B Sulfate API Sales Value by Region (2021-2032)
  7. 6.4.1 Global Polymyxin B Sulfate API Sales Value by Region: 2021-2026
  8. 6.4.2 Global Polymyxin B Sulfate API Sales Value by Region (2027-2032)
  9. 6.5 Global Polymyxin B Sulfate API Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Polymyxin B Sulfate API Sales Value (2021-2032)
  12. 6.6.2 North America Polymyxin B Sulfate API Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Polymyxin B Sulfate API Sales Value (2021-2032)
  15. 6.7.2 Europe Polymyxin B Sulfate API Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Polymyxin B Sulfate API Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Polymyxin B Sulfate API Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Polymyxin B Sulfate API Sales Value (2021-2032)
  21. 6.9.2 South America Polymyxin B Sulfate API Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Polymyxin B Sulfate API Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Polymyxin B Sulfate API Sales Value Share by Country, 2025 VS 2032
7 Polymyxin B Sulfate API Country-level Sales and Value Analysis
  1. 7.1 Global Polymyxin B Sulfate API Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Polymyxin B Sulfate API Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Polymyxin B Sulfate API Sales by Country (2021-2032)
  4. 7.3.1 Global Polymyxin B Sulfate API Sales by Country (2021-2026)
  5. 7.3.2 Global Polymyxin B Sulfate API Sales by Country (2027-2032)
  6. 7.4 Global Polymyxin B Sulfate API Sales Value by Country (2021-2032)
  7. 7.4.1 Global Polymyxin B Sulfate API Sales Value by Country (2021-2026)
  8. 7.4.2 Global Polymyxin B Sulfate API Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Polymyxin B Sulfate API Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Polymyxin B Sulfate API Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Polymyxin B Sulfate API Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yancheng Youhua Pharmaceutical And Chemical Technology
  2. 8.1.1 Yancheng Youhua Pharmaceutical And Chemical Technology Company Information
  3. 8.1.2 Yancheng Youhua Pharmaceutical And Chemical Technology Business Overview
  4. 8.1.3 Yancheng Youhua Pharmaceutical And Chemical Technology Polymyxin B Sulfate API Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yancheng Youhua Pharmaceutical And Chemical Technology Polymyxin B Sulfate API Product Portfolio
  6. 8.1.5 Yancheng Youhua Pharmaceutical And Chemical Technology Recent Developments
  7. 8.2 Shandong Luxi Pharmaceutical
  8. 8.2.1 Shandong Luxi Pharmaceutical Company Information
  9. 8.2.2 Shandong Luxi Pharmaceutical Business Overview
  10. 8.2.3 Shandong Luxi Pharmaceutical Polymyxin B Sulfate API Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shandong Luxi Pharmaceutical Polymyxin B Sulfate API Product Portfolio
  12. 8.2.5 Shandong Luxi Pharmaceutical Recent Developments
  13. 8.3 Jiangxi Nuclear Industry Reyphon Bio-Chemical
  14. 8.3.1 Jiangxi Nuclear Industry Reyphon Bio-Chemical Company Information
  15. 8.3.2 Jiangxi Nuclear Industry Reyphon Bio-Chemical Business Overview
  16. 8.3.3 Jiangxi Nuclear Industry Reyphon Bio-Chemical Polymyxin B Sulfate API Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Jiangxi Nuclear Industry Reyphon Bio-Chemical Polymyxin B Sulfate API Product Portfolio
  18. 8.3.5 Jiangxi Nuclear Industry Reyphon Bio-Chemical Recent Developments
  19. 8.4 North China Pharmaceutical Huasheng
  20. 8.4.1 North China Pharmaceutical Huasheng Company Information
  21. 8.4.2 North China Pharmaceutical Huasheng Business Overview
  22. 8.4.3 North China Pharmaceutical Huasheng Polymyxin B Sulfate API Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 North China Pharmaceutical Huasheng Polymyxin B Sulfate API Product Portfolio
  24. 8.4.5 North China Pharmaceutical Huasheng Recent Developments
  25. 8.5 Hangzhou Zhongmei Huadong Pharmaceutical
  26. 8.5.1 Hangzhou Zhongmei Huadong Pharmaceutical Company Information
  27. 8.5.2 Hangzhou Zhongmei Huadong Pharmaceutical Business Overview
  28. 8.5.3 Hangzhou Zhongmei Huadong Pharmaceutical Polymyxin B Sulfate API Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hangzhou Zhongmei Huadong Pharmaceutical Polymyxin B Sulfate API Product Portfolio
  30. 8.5.5 Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments
  31. 8.6 Ganzhou Ruizhi Pharmaceutical
  32. 8.6.1 Ganzhou Ruizhi Pharmaceutical Company Information
  33. 8.6.2 Ganzhou Ruizhi Pharmaceutical Business Overview
  34. 8.6.3 Ganzhou Ruizhi Pharmaceutical Polymyxin B Sulfate API Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Ganzhou Ruizhi Pharmaceutical Polymyxin B Sulfate API Product Portfolio
  36. 8.6.5 Ganzhou Ruizhi Pharmaceutical Recent Developments
  37. 8.7 Xellia Pharmaceuticals Aps
  38. 8.7.1 Xellia Pharmaceuticals Aps Company Information
  39. 8.7.2 Xellia Pharmaceuticals Aps Business Overview
  40. 8.7.3 Xellia Pharmaceuticals Aps Polymyxin B Sulfate API Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Xellia Pharmaceuticals Aps Polymyxin B Sulfate API Product Portfolio
  42. 8.7.5 Xellia Pharmaceuticals Aps Recent Developments
  43. 8.8 Rochem International
  44. 8.8.1 Rochem International Company Information
  45. 8.8.2 Rochem International Business Overview
  46. 8.8.3 Rochem International Polymyxin B Sulfate API Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Rochem International Polymyxin B Sulfate API Product Portfolio
  48. 8.8.5 Rochem International Recent Developments
  49. 8.9 Medisca
  50. 8.9.1 Medisca Company Information
  51. 8.9.2 Medisca Business Overview
  52. 8.9.3 Medisca Polymyxin B Sulfate API Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Medisca Polymyxin B Sulfate API Product Portfolio
  54. 8.9.5 Medisca Recent Developments
  55. 8.10 LGM Pharma
  56. 8.10.1 LGM Pharma Company Information
  57. 8.10.2 LGM Pharma Business Overview
  58. 8.10.3 LGM Pharma Polymyxin B Sulfate API Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 LGM Pharma Polymyxin B Sulfate API Product Portfolio
  60. 8.10.5 LGM Pharma Recent Developments
  61. 8.11 ChemWerth
  62. 8.11.1 ChemWerth Company Information
  63. 8.11.2 ChemWerth Business Overview
  64. 8.11.3 ChemWerth Polymyxin B Sulfate API Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 ChemWerth Polymyxin B Sulfate API Product Portfolio
  66. 8.11.5 ChemWerth Recent Developments
  67. 8.12 Biotika As
  68. 8.12.1 Biotika As Company Information
  69. 8.12.2 Biotika As Business Overview
  70. 8.12.3 Biotika As Polymyxin B Sulfate API Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Biotika As Polymyxin B Sulfate API Product Portfolio
  72. 8.12.5 Biotika As Recent Developments
  73. 8.13 Alp Pharm
  74. 8.13.1 Alp Pharm Company Information
  75. 8.13.2 Alp Pharm Business Overview
  76. 8.13.3 Alp Pharm Polymyxin B Sulfate API Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Alp Pharm Polymyxin B Sulfate API Product Portfolio
  78. 8.13.5 Alp Pharm Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Polymyxin B Sulfate API Value Chain Analysis
  2. 9.1.1 Polymyxin B Sulfate API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Polymyxin B Sulfate API Sales Mode & Process
  6. 9.2 Polymyxin B Sulfate API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Polymyxin B Sulfate API Distributors
  9. 9.2.3 Polymyxin B Sulfate API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst